SCHEMBL25706030

SCHEMBL25706030

CC(C)NC(=O)O[C@@H]1C[C@@H]2CCCC[C@]2(C)[C@H]2CC[C@]3(C)[C@@H]([C@H](C)CCC(=O)O)CC[C@H]3[C@H]12

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GPBAR1 Q8TDU6 8/20 0.72
▸ NR1H4 Q96RI1 4/20 0.72
▸ MEN1 O00255 3/20 0.64
▸ KMT2A Q03164 3/20 0.64
▸ LMNA P02545 2/20 0.64
▸ TDP1 Q9NUW8 2/20 0.64
▸ EPHA2 P29317 2/20 0.64
▸ AKR1B10 O60218 1/20 0.64
▸ AKR1B1 P15121 1/20 0.64
▸ EFNA1 P20827 1/20 0.64
▸ PSEN1 P49768 1/20 0.64
▸ PSEN2 P49810 1/20 0.64
▸ APH1B Q8WW43 1/20 0.64
▸ NCSTN Q92542 1/20 0.64
▸ APH1A Q96BI3 1/20 0.64
▸ PSENEN Q9NZ42 1/20 0.64
▸ HSD17B10 Q99714 1/20 0.64
▸ ABCB11 O95342 2/20 0.57
▸ SLC10A2 Q12908 2/20 0.57
▸ CYP2C19 P33261 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23845897 0.91 GPBAR1 (0.78) GPBAR1NR1H4MEN1KMT2ALMNA
SCHEMBL25706108 0.91 GPBAR1 (0.78) GPBAR1NR1H4MEN1KMT2ALMNA
SCHEMBL19858469 0.88 GPBAR1 (0.80) GPBAR1NR1H4MEN1KMT2ALMNA
SCHEMBL19858468 0.88 GPBAR1 (0.80) GPBAR1NR1H4MEN1KMT2ALMNA
SCHEMBL17303267 0.86 GPBAR1 (0.74) GPBAR1NR1H4MEN1KMT2ALMNA
SCHEMBL21710942 0.85 GPBAR1 (0.72) GPBAR1NR1H4MEN1KMT2ALMNA
SCHEMBL24897216 0.84 GPBAR1 (1.00) GPBAR1NR1H4MEN1KMT2ALMNA
SCHEMBL21710850 0.84 GPBAR1 (1.00) GPBAR1NR1H4MEN1KMT2ALMNA
SCHEMBL23483146 0.84 GPBAR1 (1.00) GPBAR1NR1H4MEN1KMT2ALMNA
SCHEMBL22626977 0.84 GPBAR1 (1.00) GPBAR1NR1H4MEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230183292-A1 IMMUNOMODULATORS BRISTOL MYERS SQUIBB CO (US) 2023-06-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230183292-A1 IMMUNOMODULATORS CD274, PDCD1LG2, PDCD1 GPBAR1 1598/4885NR1H4 2311/4885MEN1 3220/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback